Yang L - Search Results

1

Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients.

Cho EC, Kuo ML, Liu X, Yang L, Hsieh YC, Wang J, Cheng Y, Yen Y. Cho EC, et al. Among authors: yang l. Oncotarget. 2014 Jul 15;5(13):4834-44. doi: 10.18632/oncotarget.2044. Oncotarget. 2014. PMID: 24947616 Free PMC article.

2

Early finding of chest wall metastasis of hepatocellular carcinoma in a woman by fluorodeoxyglucose-positron emission tomography scan: a case report.

Yang L, Marx H, Yen Y. Yang L, et al. J Med Case Rep. 2011 Apr 13;5:147. doi: 10.1186/1752-1947-5-147. J Med Case Rep. 2011. PMID: 21489297 Free PMC article.

3

Inhibitors of mTOR overcome drug resistance from topoisomerase II inhibitors in solid tumors.

Gaur S, Chen L, Yang L, Wu X, Un F, Yen Y. Gaur S, et al. Among authors: yang l. Cancer Lett. 2011 Dec 1;311(1):20-8. doi: 10.1016/j.canlet.2011.06.005. Epub 2011 Jun 29. Cancer Lett. 2011. PMID: 21764510

4

Identification of an AAA ATPase VPS4B-dependent pathway that modulates epidermal growth factor receptor abundance and signaling during hypoxia.

Lin HH, Li X, Chen JL, Sun X, Cooper FN, Chen YR, Zhang W, Chung Y, Li A, Cheng CT, Yang L, Deng X, Liu X, Yen Y, Johnson DL, Shih HM, Yang A, Ann DK. Lin HH, et al. Among authors: yang a, yang l. Mol Cell Biol. 2012 Mar;32(6):1124-38. doi: 10.1128/MCB.06053-11. Epub 2012 Jan 17. Mol Cell Biol. 2012. PMID: 22252323 Free PMC article.

5

MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways.

Zhang L, Yang L, Liu X, Chen W, Chang L, Chen L, Loera S, Chu P, Huang WC, Liu YR, Yen Y. Zhang L, et al. Among authors: yang l. Hepatology. 2013 May;57(5):1919-30. doi: 10.1002/hep.26162. Epub 2013 Apr 5. Hepatology. 2013. PMID: 23175432

6

Wnt modulates MCL1 to control cell survival in triple negative breast cancer.

Yang L, Perez AA, Fujie S, Warden C, Li J, Wang Y, Yung B, Chen YR, Liu X, Zhang H, Zheng S, Liu Z, Ann D, Yen Y. Yang L, et al. BMC Cancer. 2014 Feb 24;14:124. doi: 10.1186/1471-2407-14-124. BMC Cancer. 2014. PMID: 24564888 Free PMC article. Clinical Trial.

7

Mutants TP53 p.R273H and p.R273C but not p.R273G enhance cancer cell malignancy.

Li J, Yang L, Gaur S, Zhang K, Wu X, Yuan YC, Li H, Hu S, Weng Y, Yen Y. Li J, et al. Among authors: yang l. Hum Mutat. 2014 May;35(5):575-84. doi: 10.1002/humu.22528. Epub 2014 Apr 7. Hum Mutat. 2014. PMID: 24677579

8

Reciprocal regulation of autophagy and dNTP pools in human cancer cells.

Chen W, Zhang L, Zhang K, Zhou B, Kuo ML, Hu S, Chen L, Tang M, Chen YR, Yang L, Ann DK, Yen Y. Chen W, et al. Among authors: yang l. Autophagy. 2014 Jul;10(7):1272-84. doi: 10.4161/auto.28954. Epub 2014 May 16. Autophagy. 2014. PMID: 24905824 Free PMC article.

9

The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.

Tzeng HE, Yang L, Chen K, Wang Y, Liu YR, Pan SL, Gaur S, Hu S, Yen Y. Tzeng HE, et al. Among authors: yang l. Oncotarget. 2015 May 10;6(13):11061-73. doi: 10.18632/oncotarget.3568. Oncotarget. 2015. PMID: 25857298 Free PMC article.

10

Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer.

Luu T, Kim KP, Blanchard S, Anyang B, Hurria A, Yang L, Beumer JH, Somlo G, Yen Y. Luu T, et al. Among authors: yang l. Breast Cancer Res Treat. 2018 Jan;167(2):469-478. doi: 10.1007/s10549-017-4516-x. Epub 2017 Sep 27. Breast Cancer Res Treat. 2018. PMID: 28956187 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53,314 results

Search Page